Results mixed on monoclonal antibody use against COVID-19 Omicron variant
December 16, 2021 at 14:48 PM EST
Regeneron and AstraZeneca, makers of COVID-19 monoclonal antibody treatments, shared mixed results Thursday on their tests against the Omicron variant of the virus.